This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of California. Active years: 2015-2026.
Company Filing History:
Years Active: 2015-2026
Title: Jau-Nian Chen: Innovator in Cardiac and Cholesterol Regulation
Introduction
Jau-Nian Chen is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the fields of cardiac health and cholesterol regulation. With a total of 3 patents, his work focuses on innovative solutions to pressing medical challenges.
Latest Patents
Chen's latest patents include groundbreaking inventions. The first patent involves anti-arrhythmicity agents, which are agents, compositions, and methods for regulating cardiac rhythmicity. The second patent addresses chemical inhibitors of cholesterol biosynthesis and venous angiogenesis. This invention relates to a compound known as aplexone, along with pharmaceutically acceptable salts and solvates, and functional variants thereof. Methods of using these compounds and pharmaceutical compositions to inhibit angiogenesis and reduce cellular cholesterol levels are also included.
Career Highlights
Jau-Nian Chen is affiliated with the University of California, where he continues to advance research in his areas of expertise. His work has garnered attention for its potential impact on public health.
Collaborations
Some of his notable coworkers include Ohyun Kwon and Jie Huang, who contribute to the collaborative research environment at the University of California.
Conclusion
Jau-Nian Chen's innovative patents and research efforts highlight his commitment to improving health outcomes related to cardiac and cholesterol issues. His contributions are paving the way for future advancements in these critical areas.